Related Experiment Videos
[The effect of neoplastic hyperprolactinemia on bone density]
R Baldelli1, G Perrone, M R Nardone
1Istituto di Clinica Medica V, Università degli Studi di Roma, La Sapienza, Roma.
Minerva Endocrinologica
|March 1, 1996
Summary
Bone density loss in hyperprolactinemia is linked to prolonged amenorrhea and low estrogen, not directly to high prolactin levels. This study clarifies the cause of demineralization in affected patients.
Area of Science:
- Endocrinology
- Bone Metabolism
- Reproductive Health
Background:
- Hyperprolactinemia is associated with reduced bone mass density in young patients.
- The exact mechanism behind this bone demineralization remains unclear, with a direct role for prolactin (PRL) suggested.
- Understanding the origin of bone loss is crucial for effective patient management.
Purpose of the Study:
- To investigate the origin of bone demineralization in hyperprolactinemia.
- To evaluate the relationship between prolactin-secreting pituitary adenomas, menstrual irregularities, and bone mineral density (BMD).
- To differentiate the effects of hyperprolactinemia from hypoestrogenism and amenorrhea duration on BMD.
Main Methods:
- Evaluated BMD in 24 patients with prolactin-secreting pituitary adenomas.
- Subdivided patients into three groups based on menstrual characteristics: oligomenorrhoea (OM), amenorrhea <2 years (AMa), and long-lasting amenorrhea (AMb).
- Compared BMD at L2-L4 and thighbone levels with 12 women with normal menstrual cycles (controls).
Main Results:
- BMD values were significantly reduced in the long-lasting amenorrhea (AMb) group compared to other subgroups and controls.
- No significant difference in BMD was observed between the oligomenorrhoea (OM) and shorter amenorrhea (AMa) groups.
- The findings suggest bone demineralization is secondary to hypoestrogenism and amenorrhea duration.
Conclusions:
- Bone mass density reduction in patients with prolactin-secreting pituitary adenomas is primarily a consequence of hypoestrogenism and the duration of amenorrhea.
- The direct role of elevated prolactin levels in causing bone demineralization appears less significant than previously hypothesized.
- These results emphasize the importance of managing menstrual irregularities and estrogen deficiency in hyperprolactinemic patients to preserve bone health.